Finance

Beta
Lists
PEB:ASX
Pacific Edge Ltd
A$0.24
+4.44%
(+0.010) 1D
Jun 3, 4:10:28 PM GMT+10  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for PEB...
Open
A$0.23
High
A$0.24
Low
A$0.23
Mkt. cap
328.16M
Avg. vol.
67.89K
Volume
130.40K
52-wk high
A$0.25
52-wk low
A$0.08
No. of employees
114
Open
A$0.23
High
A$0.24
Low
A$0.23
Mkt. cap
328.16M
Avg. vol.
67.89K
Volume
130.40K
52-wk high
A$0.25
52-wk low
A$0.08
No. of employees
114
News stories
From sources across the web
Profile
Pacific Edge Limited, based in New Zealand, focuses on cancer diagnostics with a suite of bladder cancer diagnostic tools using genetic biomarkers. The company operates with a head office in Dunedin, New Zealand, and also has an office in Hershey, USA. It is listed on the Australian ASX and the New Zealand NZX main board stock exchange. Wikipedia
About Pacific Edge Ltd
CEO-
Employees114
Founded2001
Headquarters-
SectorBiotechnology
Websitepacificedgedx.com
Previous reportsAll values in NZD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in NZD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
3.42M
3.42M
3.09M
3.09M
Cost of goods sold
2.94M
2.94M
2.86M
2.86M
Cost of revenue
2.94M
2.94M
2.86M
2.86M
Research and development expenses
3.53M
3.53M
3.18M
3.18M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.64M
6.64M
5.52M
5.52M
Operating expense
10.18M
10.18M
8.70M
8.70M
Total operating expenses
13.12M
13.12M
11.56M
11.56M
Operating income
-9.70M
-9.70M
-8.47M
-8.47M
Other non operating income
-
-
-
-
EBT including unusual items
-9.56M
-9.56M
-8.33M
-8.33M
EBT excluding unusual items
-9.56M
-9.56M
-8.36M
-8.36M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9.56M
-9.56M
-8.33M
-8.33M
Net profit margin
-279.64%
-279.64%
-269.79%
-269.79%
Earnings per share
-
-
-
-
Interest and investment income
149.50K
149.50K
111.00K
111.00K
Interest expense
-
-
-
-
Net interest expenses
149.50K
149.50K
111.00K
111.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-9.40M
-9.40M
-8.34M
-8.34M
Gain or loss from assets sale
-11.50K
-11.50K
6.50K
6.50K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer